Azelis Group (AZE) H1 2025 earnings summary

Executive summary

• Revenue reached €2.2bn in H1 2025, up 0.6% year-over-year (+3.3% constant currency), with 1.2% organic growth and 2.2% from acquisitions, offset by FX headwinds and market volatility.

• Net profit declined 14.6% to €85.5m, mainly due to lower operating profit and margin contraction.

• Free cash flow increased 10.8% to €151m, with cash conversion up to 63.8% from 53.3% a year ago.

• Three acquisitions (Solchem in Spain, S Amit in India, ACEF in Italy) completed or announced, expanding presence and market reach.

• Management remains focused on cost savings, innovation, sustainability, and digitalization to drive long-term value and resilience.

Financial highlights

• Revenue: €2.2bn (+0.6% year-over-year, +3.3% constant currency); organic growth 1.2%, acquisitions 2.2%, FX headwind 2.7%.

• Gross profit: €515m, down 2.2% year-over-year; gross margin contracted by 68 bps to 23.9%.

• Adjusted EBITA: €234m (margin 10.9%), down 7.7% year-over-year; adjusted EBITDA: €257m (margin 11.9%), down 6.6%.

• Net financial expense decreased 3.4% to €69.9m, mainly due to lower interest expense.

• Free cash flow: €151m, up 10.8% year-over-year; conversion margin improved to 63.8%.

Outlook and guidance

• Macro uncertainty from tariffs, geopolitical instability, and regional conflicts continues to weigh on demand.

• Cost-saving program (EUR 20m annualized run-rate) to deliver half of savings in H2 2025; focus on cost control and cash preservation.

• Asset-light model and disciplined cost/working capital management to support resilience and cash generation.

• Targeting leverage back within 2.5x–3.0x range; M&A to resume once leverage stabilizes.

• Long-term sector fundamentals remain attractive, with confidence in strategy to capture industry opportunities.